| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/08/2009 | US7585938 Gamma-secretase inhibitors |
| 09/08/2009 | US7585937 GAG binding proteins |
| 09/08/2009 | US7585936 Protein expression |
| 09/08/2009 | US7585849 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 09/08/2009 | US7585844 Myosin light chain kinase inhibitors and methods of use |
| 09/08/2009 | US7585843 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 09/08/2009 | US7585840 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 09/08/2009 | US7585835 GASP1: a follistatin domain containing protein |
| 09/08/2009 | US7585834 Transport moiety comprises a structure; (ZYZ)nZ, (ZY)nZ, (ZYY)nZ or (ZYYY)nZ, wherein each Z is L-arginine or D-arginine, and each Y is independently an amino acid that does not comprise an amidino or guanidino moiety; n=2-10 |
| 09/08/2009 | US7585674 Sporulation defective transgenic bacillus for use as bioreactors for generation of proteins useful in foodstuffs, drugs, cosmetics, detergents and fiber treatments |
| 09/08/2009 | US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 09/08/2009 | US7585671 Hedgehog interacting proteins and uses related thereto |
| 09/08/2009 | US7585669 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity |
| 09/08/2009 | US7585658 Staphylococcus aureus antigenic polypeptides and compositions |
| 09/08/2009 | US7585653 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 09/08/2009 | US7585648 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/08/2009 | US7585647 with changed spatial configuration and improved efficacy; preventing or treating viral diseases; also an artificial gene which codes for the interferon |
| 09/08/2009 | US7585646 Human GIL-19/AE289 polynucleotides and methods of producing the encoded polypeptides |
| 09/08/2009 | US7585639 Methods for modulating ATP-binding cassette transmembrane reporter protein expression |
| 09/08/2009 | US7585637 Estrogen related receptor, ERRα, a regulator of bone formation |
| 09/08/2009 | US7585623 Syndrome X, metabolic syndrome, multiple risk factor syndrome, insulin resistant syndrome, deadly quartet, and visceral fat syndrome, diabetes, obesity, hypercholesterolemia, and hyperlipoproteinemias, hyperlipidemia, arteriosclerosis, hypertonia, circulatory system disease, hyperphagia |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585620 Method for identifying and for extracting endotoxin |
| 09/08/2009 | US7585619 Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity |
| 09/08/2009 | US7585522 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | US7585506 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/08/2009 | US7585505 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 09/08/2009 | US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization |
| 09/08/2009 | US7585497 Comprises nucleotide sequences coding insulin-like growth factor binding protein-3 and receptors for diagnosis, prevention and treatment of cancer; antitumor/anticarcinogenic agents |
| 09/08/2009 | US7585496 Stable pharmaceutical composition granulocyte-colony stimulating factor |
| 09/08/2009 | US7585495 Peptide-based hair conditioners and hair colorants consist of a shampoo-resistant hair-binding peptide coupled to a hair conditioning agent or a coloring agent, respectively; hair care and hair coloring product compositions |
| 09/08/2009 | CA2409546C Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/08/2009 | CA2355466C Multi-component vaccine comprising at least two antigens from haemophilus influenzae |
| 09/08/2009 | CA2294701C Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 09/08/2009 | CA2265505C An immune disease remedy, treatment method and preventive agent and method for dogs and cats |
| 09/04/2009 | CA2658231A1 Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo |
| 09/03/2009 | WO2009108898A2 Production and uses of type 1 ribosome inactivating proteins |
| 09/03/2009 | WO2009108890A1 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 09/03/2009 | WO2009108807A1 Glycopeptides and methods of making and using them |
| 09/03/2009 | WO2009108797A1 An engineered cxcl12 alpha locked dimer polypeptide |
| 09/03/2009 | WO2009108774A2 Use of synthetic scaffolds for the production of biosynthetic pathway products |
| 09/03/2009 | WO2009108307A2 Diagnostic uses of anti-h8 monoclonal antibodies |
| 09/03/2009 | WO2009108274A2 Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| 09/03/2009 | WO2009108261A2 Compositions and methods for the treatment of viral infections |
| 09/03/2009 | WO2009107900A1 Exendin derivative linked biotin, method for the preparation thereof and pharmaceutical composition comprising the same |
| 09/03/2009 | WO2009107822A1 Mutant gene capable of controlling the oil-and-fat content in seed, and method for controlling the oil-and-fat content in seed |
| 09/03/2009 | WO2009107158A1 Monospecific antibody and method of production using as antigen an isoform of the human fad synthetase. |
| 09/03/2009 | WO2009107143A2 Line edge roughness measuring technique and test structure |
| 09/03/2009 | WO2009106882A1 Cytochrome b5 knockout animal models |
| 09/03/2009 | WO2009106819A2 Biological materials and uses thereof |
| 09/03/2009 | WO2009106795A1 Enzyme |
| 09/03/2009 | WO2009106666A1 Recombinant antigen |
| 09/03/2009 | WO2009106596A2 Plants with increased yield |
| 09/03/2009 | WO2009106532A2 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 09/03/2009 | WO2009106488A1 Method for increasing expression yield of a protein of interest |
| 09/03/2009 | WO2009106362A1 Dna vaccine for the therapy and prophylaxis of cervical cancer and the premalignant precursors thereof |
| 09/03/2009 | WO2009106343A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 09/03/2009 | WO2009106239A1 Selenium containing modifying agents and conjugates |
| 09/03/2009 | WO2009106102A1 Optimized adhesin fragments and corresponding nanoparticles |
| 09/03/2009 | WO2009105890A1 Methods and kits for detecting congenital stationary night blindness and selecting different coat patterns |
| 09/03/2009 | WO2009105833A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 09/03/2009 | WO2009088735A3 Novel bacillus thuringiensis gene with coleopteran activity |
| 09/03/2009 | WO2009059804A3 T-cell receptor peptides specific for part of cd20, uses thereof, and methods of preparing cytotoxic t-cells |
| 09/03/2009 | WO2009043466A3 Therapeutic use of the peptide gluten exorphin a5 |
| 09/03/2009 | WO2009043455A3 Therapeutic uses of angiogenin 108-122 and gluten exorphin a5 |
| 09/03/2009 | WO2008151845A3 Methods for producing glycosylated human alpha-1 antitrypsin (a1at) in mammalian host cells |
| 09/03/2009 | WO2008077522A3 Use of polypeptides as coccidiostat and /or histomonastat |
| 09/03/2009 | WO2008047006A9 Polynucleotides and polypeptides coded by said polynucleotides involved in the biosynthesis of congocidine and derivatives thereof |
| 09/03/2009 | WO2007054949A3 Improved variants of pigment epithelium derived factor and uses thereof |
| 09/03/2009 | US20090222952 Plants Having Improved Growth Characteristics And A Method For Making The Same |
| 09/03/2009 | US20090222931 Novel identified oncogene with kinase-domain (nok) |
| 09/03/2009 | US20090221802 heterodimeric receptor complex comprising a receptor polypeptide and a interleukin-2 gamma receptor polypeptide, used for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; antibodies; immunology |
| 09/03/2009 | US20090221800 Method for the Production of Recombinant Proteins |
| 09/03/2009 | US20090221799 Novel Fluorescent and Colored Proteins, and Polynucleotides That Encode These Proteins |
| 09/03/2009 | US20090221798 comprises polypeptide comprised of extracellular and transmembrane domains; modulate sweet or umami taste; g-protein coupled receptors |
| 09/03/2009 | US20090221797 Heteromeric taste receptors |
| 09/03/2009 | US20090221796 Heteromeric taste receptors |
| 09/03/2009 | US20090221795 Active truncated form of the rna polymerase of flavivirus |
| 09/03/2009 | US20090221794 Human Protooncogene and Protein Encoded By Same |
| 09/03/2009 | US20090221790 Method for stabilization of proteins using non-natural amino acids |
| 09/03/2009 | US20090221789 Crystalline Polypeptides |
| 09/03/2009 | US20090221718 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 09/03/2009 | US20090221709 METHODS OF MODIFYING TASTE SENSATION IN AN ANIMAL USING COMPOUNDS THAT MODULATE T1R1/T1R3 Or T1R2/T1R3 RECEPTORS |
| 09/03/2009 | US20090221672 Biomarker for Prostate Cancer |
| 09/03/2009 | US20090221670 Method for diagnosis and treatment of a mental disease |
| 09/03/2009 | US20090221630 Iap inhibitors |
| 09/03/2009 | US20090221509 Tumour-associated peptides binding to MHC-molecules |
| 09/03/2009 | US20090221508 Immunomodulatory and anti-tumour peptides |
| 09/03/2009 | US20090221505 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
| 09/03/2009 | US20090221501 toxin complex (TC) proteins, obtained from Xenorhabdus, Photorhabdus, and Paenibacillus; toxicity of an insectidal protein is enhanced by a potentiator protein of a different organism; reduces the number of genes (and transformation events) needed to be coexpressed by transgenic plants for insect control |
| 09/03/2009 | US20090221500 Modified toxins |
| 09/03/2009 | US20090221499 Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide; for use in induction of immune responses |
| 09/03/2009 | US20090221493 Ocl-2a3 compositions and uses thereof |
| 09/03/2009 | US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals |
| 09/03/2009 | US20090221491 Purification and Use of a Factor for Supporting Wound Healing |
| 09/03/2009 | US20090221485 Oral peptides conjugates for metabolic diseases |
| 09/03/2009 | US20090221483 Antimicrobial Cathelicidin Peptides |
| 09/03/2009 | US20090221482 Tissue protective peptides and uses thereof |
| 09/03/2009 | US20090221481 Stimulatory auto-antibodies to the pdgf receptors as pathology marker and therapeutic target |